课题基金 / 基金详情

Pathobiology of alpha-1-antitrypsin deficency and the serpinopathies

Pathobiology of alpha-1-antitrypsin deficency and the serpinopathies
α-1-抗胰蛋白酶缺乏症和丝氨酸病的病理学
批准号:
G0901786-E01/2
负责人:
David Lomas
金额:
$145.47万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --

项目摘要

项目成果

David Lomas的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The serine proteinase inhibitors or serpins are a family of proteins that play an important role in controlling enzymes within the human body. Naturally occurring mutations cause the protein to change shape and accumulate as chains of polymers within the cell of synthesis. This causes cell death and hence either cirrhosis (if the protein accumulates within the liver) or dementia (if it accumulates within the brain). We propose to assess the mechanism by which polymers form and their effect on the cells in which they are synthesised. We also propose to determine the mechanism of action of small molecules that we have identified that can block polymer formation in the test tube and reduce the accumulation of mutant protein in a cell model of disease. We have shown that mutations that favour the formation of polymers also favour the formation of an inactive latent conformation. We propose to develop new monoclonal antibodies to the latent conformation of the serpins alpha-1-antitrypsin and neuroserpin so that we can identify them in biological tissues and so evaluate their role in disease. Polymers of alpha-1-antitrypsin form spontaneously within the lungs of individuals with alpha-1-antitrypsin deficiency where they inactivate alpha-1-antitrypsin as a proteinase inhibitor as well as acting as a chemoattractant to recruit inflammatory cells to the lung. We will use our antibody to polymers of alpha-1-antitrypsin to develop a new assay to image pathological polymers within the lung. This will provide useful information on the clearance of polymers from the lung and perhaps the progression of lung disease in individuals with alpha-1-antitrypsin deficiency.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural and cellular basis of alpha-1-antitrypsin (AT) deficiency and the serpinopathies
  • 批准号:
    MR/V034243/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $205.63万
  • 财政年份:
    2021
  • 负责人:
    David Lomas
  • 依托单位:
Alpha-1-antitrypsin (AT) deficiency and the serpinopathies: pathobiology and new therapeutic strategies
  • 批准号:
    MR/N024842/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $260.94万
  • 财政年份:
    2016
  • 负责人:
    David Lomas
  • 依托单位:
MICA: Medical Bioinformatics: Data-Driven Discovery for Personalised Medicine
  • 批准号:
    MR/L016311/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $1130.97万
  • 财政年份:
    2014
  • 负责人:
    David Lomas
  • 依托单位:
Pathobiology of alpha-1-antitrypsin deficency and the serpinopathies
  • 批准号:
    G0901786-E01/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $228.98万
  • 财政年份:
    2011
  • 负责人:
    David Lomas
  • 依托单位:
国内基金
海外基金
基于PTEN/Akt1/HIF-1alpha通路探讨六仁通便汤改善功能性便秘的机制
  • 批准号:
    2025JJ81110
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    喻融
  • 依托单位:
Vdelta2-T细胞外泌体疫苗携带IFN-gamma和TNF-alpha诱导抗原提呈细胞成熟并促进EBV肿瘤免疫应答的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    王系伟
  • 依托单位:
NOX4-PKC alpha 介导的铁死亡在帕金森病多 巴胺能神经元变性中的作用及机制
  • 批准号:
    Y24H090030
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    田均
  • 依托单位:
肾上腺素能受体alpha2A在胃袖损伤修复中的作用机制和应用研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    于腾波
  • 依托单位: